WESTON, FL -- (Marketwire) -- 03/13/09 -- Wall Street News Alert's "stocks to watch" this morning are: Oncolin Therapeutics, Inc. (PINKSHEETS: OCOL), General Motors Corp. (NYSE: GM), Genentech Inc. (NYSE: DNA), and Pfizer Inc. (NYSE: PFE).
To receive FREE Mobile Stock Alerts formatted especially for your cell phone, text the word "press" in the subject line to 68494.
*** This free service can be discontinued at any time by replying to any one of the alerts with the word "stop."
Yesterday after the markets closed, the company, Oncolin Therapeutics, Inc. (PINKSHEETS: OCOL), which focuses on renewable and traditional energy resources as well as assists in the development and advancement of Intertech Bio, a biopharmaceutical company that engages in the discovery, development and commercialization of novel selective anticancer therapies, announced that it has identified a new prospect located in Louisiana with over 1,000,000 barrels of potential oil reserves. This prospect area has twenty-three wells that were previously drilled and consists of approximately 600 acres. Oncolin will initially evaluate the viability of re-entering the existing well bores which is traditionally much less than drilling new wells.
This prospect is in line with the company's new focus of developing existing well bores and re-entering wells behind existing pipe to produce oil and gas. This allows the company to reduce costs and generate substantial higher investment returns and also minimizes the risks and high capital costs typically associated with drilling new wells. The company accomplishes this by employing the latest seismic, directional drilling, logging, and completion technologies.
The stock closed yesterday at around One cent a share.
For an in-depth profile of Oncolin Therapeutics, Inc., visit http://www.wallstreetnewsalert.com/view-company-profiles.php?profile=OCOL_031109
General Motors Corp. (NYSE: GM) as of 10:45 am EST. up 23.9% on 16.1 million shares traded.
General Motors Corp. is one of the world's largest automakers. With global headquarters in Detroit, GM manufactures its cars and trucks in 35 countries.
Genentech Inc. (NYSE: DNA) as of 10:45 am EST. up 0.1% on 7.6 million shares traded.
Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with significant unmet medical needs.
Pfizer Inc. (NYSE: PFE) as of 10:45 am EST. up 2% on 21.1 million shares traded.
Pfizer Inc., founded in 1849, is dedicated to better health and greater access to health care for people and their valued animals.
Market News: World stock markets rallied again Friday as confidence remained buoyed by positive U.S. economic data, hopes of further stimulus measures from Japan and China and upbeat comments from U.S. bank executives.
Let Wall Street News Alert help advertise for your company using our effective awareness campaigns. If you're Interested in telling your story, we can help. Contact us at email@example.com
WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of often-overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 200 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at http://www.wallstreetnewsalert.com.
*** It has come to the attention of Wall Street News Alert (WSNA), that various persons or companies distribute faxes bearing similar names to Wall Street News Alert. Wall Street News Alert is not affiliated with faxes bearing names such as: Wall Street Stock Alert, Wall Street Investor Alert, Wall Street News Alert or any other fax using various combinations of the generic words Wall Street.***
Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF). WSCF also maintains a contractual, working relationship with Stock Market Alerts LLC and its Wall Street Enews brand. WSCF is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSCF research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSCF disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies' discussed in this release is highly speculative and carries a high degree of risk. WSCF is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks.
This profile is not without bias, and is a paid release. WSCF has been compensated for dissemination of company information on behalf of one or more of the companies mentioned in this release. For current services performed for Oncolin Therapeutics (PINKSHEETS: OCOL), WSCF has been compensated Fifteen Thousand dollars by the company. WSCF was also previously compensated for services rendered in 2008 and 2007. WSCF holds no shares of the stock. WSCF may receive additional compensation for extension of its services. Any additional compensation will be disclosed at such time that WSCF is aware of a client's desire to extend the original services. WSCF may have received shares of a company profiled in this release prior to the dissemination of the information in this release. WSCF may immediately sell some or any shares in a profiled company held by WSCF and may have previously sold shares in a profiled company held by WSCF. WSCF's services for a company may cause the company's stock price to increase, in which event WSCF would make a profit when it sells its stock in a company. In addition, WSCF's selling of a company's stock may have a negative effect on the market price of the stock.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSCF undertakes no obligation to update such statements.